Prelude Therapeutics
PRLD
PRLD
53 hedge funds and large institutions have $144M invested in Prelude Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
62% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 13
Holders
53
Holding in Top 10
–
Calls
$1.52M
Puts
–
Top Buyers
| 1 | +$2.22M | |
| 2 | +$830K | |
| 3 | +$230K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$225K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$116K |
Top Sellers
| 1 | -$2M | |
| 2 | -$1.93M | |
| 3 | -$834K | |
| 4 |
Two Sigma Investments
New York
|
-$782K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$621K |